1,4-dihydropyridines

Details 1,4-dihydropyridines 1,4-dihydropyridines

1987-01-12

1989-05-23

Fan, Jane T.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546167, A61K 3144, C07D40104

Patent

active

048331503

ABSTRACT:
Compounds having calcium channel antagonist activity of the formula: ##STR1## wherein R.sub.1 and R.sub.2 are each independently amino, trifluoromethyl, pentafluoroethyl, alkoxy, lower alkenyl, or lower alkynyl or branched or unbranched lower alkyl, which is unsubstituted or is substituted with cyano, hydroxy, acyloxy, hydrazino, lower alkyl amino, or di(lower alkyl)-amino or 5 or 6 membered saturated nitrogen-containing heterocyclic-1-yl, which is unsubstituted or is substituted with oxo, hydroxy, alkyl, and hydroxy (lower alkyl) R.sub.3 is straight- or branched-chain C.sub.1 to C.sub.12 alkyl, alkenyl, alkynyl, or cycloalkyl, and is either unsubstituted or substituted with hydroxy, acyloxy, cyano, di(lower alkyl) amino 5- or 6-membered saturated nitrogen-containing heterocyclic -1-yl or R.sub.3 is --A--R.sub.4, A is a straight- or branched-chain hydrocarbon moiety containing from 2 to 12 carbon atoms and from 0 to 2 double bonds, R.sub.4 is selected from the group consisting of: ##STR2## R.sub.5 is hydrogen, nitro, cyano, azido, amino, trifluoromethyl, alkylamino, dialkylamino, halo, carboxyl, carbalkoxy, alkyl, alkenyl, alkynyl, cycloalkyl, acylamino, carboxamido, sulfonamido, and SO.sub.m -(lower)alkyl where m is 0, 1, or 2 and R.sub.6 is aryl or heteroaryl or a pharmaceutically-acceptable salt thereof are disclosed. Also disclosed is a method of treating hypertension and other disorders by administering an effective amount of a compound of the present invention.

REFERENCES:
patent: 3325505 (1967-06-01), Loev
patent: 3455945 (1969-07-01), Loev
patent: 3470297 (1969-09-01), Bossert et al.
patent: 3485847 (1969-12-01), Bossert et al.
patent: 3511837 (1970-05-01), Bossert et al.
patent: 3905970 (1975-09-01), Bossert et al.
patent: 3985758 (1976-10-01), Murakami et al.
patent: 4177278 (1979-12-01), Bossert et al.
patent: 4188395 (1980-02-01), Bossert et al.
patent: 4258042 (1981-03-01), Loev et al.
patent: 4307103 (1981-12-01), Sato et al.
patent: 4348395 (1982-09-01), Franckowiak et al.
patent: 4360520 (1982-11-01), Meyer et al.
patent: 4393070 (1983-06-01), Sato et al.
patent: 4446325 (1984-05-01), Ohno et al.
patent: 4448964 (1984-05-01), Muto et al.
patent: 4450160 (1984-05-01), Temple et al.
patent: 4478834 (1984-10-01), Shroff et al.
patent: 4483985 (1984-11-01), Wehinter et al.
patent: 4485239 (1984-11-01), Biseniex et al.
patent: 4487932 (1984-12-01), Biseniex et al.
patent: 4491581 (1985-01-01), Vogel
patent: 4491582 (1985-01-01), Loev et al.
patent: 4492703 (1985-01-01), Goldmann et al.
patent: 4495192 (1985-01-01), Muto et al.
patent: 4495356 (1922-01-01), Inoue et al.
patent: 4497808 (1985-02-01), Zimmermann et al.
patent: 4500527 (1985-02-01), Loev et al.
patent: 4500528 (1985-02-01), Loev et al.
patent: 4500532 (1985-02-01), Loev et al.
patent: 4503223 (1985-03-01), Reilly, Jr.
patent: 4505920 (1985-03-01), Loev et al.
patent: 4508719 (1985-04-01), Tricerri et al.
patent: 4520131 (1985-05-01), Loev et al.
patent: 4532248 (1985-07-01), Franckowiak et al.
patent: 4568677 (1986-02-01), Alker et al.
patent: 4622332 (1986-11-01), Wehinger et al.
patent: 4652573 (1987-03-01), Minaskanian et al.
patent: 4732985 (1988-03-01), Alker et al.
Ferry, et al., "Photoaffinity Labelling of CA.sup.2+ Channels with [.sup.3 H]azidopine," FEBS 1365 169(1), 112-118 (1984).
Thayer, et al., "An Antibody to Dihydropyridine Calcium Entry Blockers," Biochemical Pharmacology 35(24), 4479-4485 (1986).
Wolfe, et al., "Five-Membered Ring, II. Inter and Intramolecular Reactions of Simple Amines with N-Substituted Phthalimides. Methylamine as a Reagent for Removal of Phthaloyl Group from Nitrogen,"Can J Chem 48, 3372-3379 (1970).
Hogestatt, et al., "Effects of Nifedipine on Potassium-Induced Contraction and Noradrenaline Release in Cerebral and Extracranial Arteries from Rabbit," Acta Physiol Scand 114:283-296 (1982).

Affiliated with

Also associated with

Rating

1,4-dihydropyridines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,4-dihydropyridines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,4-dihydropyridines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1731002